Vida Ventures Advisors, LLC
- SEC CIK
- 0001831423
- Latest filing
- Nov 3, 2025
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed Apr 13, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 7
- 0 vs. Q4 2022
- Portfolio value
- $73.1M
- −$1.32M (−1.8%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DYNDyne Therapeutics, Inc. | COM | 2,220,034 | $25.6M | 35.0% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 3,931,818 | $15.1M | 20.7% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 2,207,772 | $13.8M | 18.9% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,798,163 | $8.88M | 12.2% | 00.0% | Unchanged | History |
| LIANYLianBio | SPONSORED ADS | 2,282,084 | $4.47M | 6.1% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 2,765,314 | $4.04M | 5.5% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,469,665 | $1.19M | 1.6% | 00.0% | Unchanged | History |